Cargando…

Successful Bacterial Engraftment Identified by Next-Generation Sequencing Predicts Success of Fecal Microbiota Transplant for Clostridioides difficile

BACKGROUND: The effectiveness of fecal microbiota transplantation (FMT), a treatment for Clostridioides difficile infection (CDI), is dependent on successful engraftment (incorporation) of donor stool. We present a method for evaluating engraftment success based on next-generation sequencing (NGS)-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazan, Sabine, Dave, Sonya, Papoutsis, Andreas J., Barrows, Brad D., Borody, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577596/ https://www.ncbi.nlm.nih.gov/pubmed/34804275 http://dx.doi.org/10.14740/gr1434

Ejemplares similares

Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing
por: Papoutsis, Andreas, et al.
Publicado: (2021)

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
por: Haifer, Craig, et al.
Publicado: (2021)

Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
por: Hazan, Sabine, et al.
Publicado: (2022)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
por: Borody, Thomas J., et al.
Publicado: (2015)

Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection
por: Staley, Christopher, et al.
Publicado: (2019)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Microbiota diversity and bacterial load after successful treatment of Clostridioides difficile infection with honey lavage in 4 patients
por: VAN KNIPPENBERG, Yara M.W., et al.
Publicado: (2021)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

Identification and engraftment of new bacterial strains by shotgun metagenomic sequence analysis in patients with recurrent Clostridioides difficile infection before and after fecal microbiota transplantation and in healthy human subjects
por: Verma, Sandeep, et al.
Publicado: (2021)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)

Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections
por: Baktash, Amoe, et al.
Publicado: (2018)

Successful Fecal Microbiota Transplant Delivered by Foley Catheter Through a Loop Ileostomy in a Patient With Severe Complicated Clostridioides difficile Infection
por: Philip, Shawn, et al.
Publicado: (2022)

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease
por: Meighani, Alireza, et al.
Publicado: (2020)

Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection
por: Cho, Young-Seok
Publicado: (2021)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
por: Yoon, Hyuk, et al.
Publicado: (2021)

Ischemic colitis complicated by Clostridioides difficile infection treated with fecal microbiota transplantation
por: Kang, Seok Hyung, et al.
Publicado: (2023)

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection
por: Brown, Jillian R.-M., et al.
Publicado: (2018)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: de la Villa, Sofía, et al.
Publicado: (2023)

The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation
por: Bachour, Salam P., et al.
Publicado: (2023)

Interactions Between Clostridioides difficile and Fecal Microbiota in in Vitro Batch Model: Growth, Sporulation, and Microbiota Changes
por: Horvat, Sabina, et al.
Publicado: (2018)

Personalized Clostridioides difficile engraftment risk prediction and probiotic therapy assessment in the human gut
por: Carr, Alex, et al.
Publicado: (2023)

The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by Clostridioides difficile
por: Crobach, Monique J. T., et al.
Publicado: (2020)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic Clostridioides difficile Colonization and Infection
por: Han, Sung-Hee, et al.
Publicado: (2020)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Ulcerative Proctitis in a Patient With a History of Fecal Microbiota Transplant for Clostridioides difficile Infection
por: Massaro, Michael, et al.
Publicado: (2020)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
por: Ali, Hiba, et al.
Publicado: (2021)

Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis
por: Song, Yi Nong, et al.
Publicado: (2021)

Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection
por: Eriksen, Lotte Lindgreen, et al.
Publicado: (2021)

Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection
por: Park, Soo-Hyun, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and Clostridioides difficile
por: Boicean, Adrian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eegf21pegms7d4o7qm1olel6aa